29-Jun-2020
Download PDF
Marksans Pharma
With reference to our letter of even date pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith revised disclosure of related party transactions for the half year ended 31st March 2020. The financial results for the quarter and year ended 31st March 2020 both standalone and consolidated were published on 2nd June 2020.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
